Follow up study of adjuvant chemotherapy trial of S-1 for breast cancer with ER-positive and HER2-negative

Follow up study of adjuvant chemotherapy trial of S-1 for breast cancer with ER-positive and HER2-negative - Follow up study of the POTENT trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039606

Enrollment

1930

Registered

2020-03-01

Start date

2021-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients included in POTENT trial (UMIN000003969)

Exclusion criteria

Exclusion criteria: Patients excluded from POTENT trial (UMIN000003969)

Design outcomes

Primary

Measure	Time frame
Overall survival	—

Secondary

Measure	Time frame
Disease-free survival, Cause of death, Site of recurrence, Treatment for recurrence, incidence of secondary cancer, treatment for secondary cancer	—

Countries

Japan

Contacts

Public ContactMasahiro Takada

Kyoto University Hospital Breast Surgery

masahiro@kuhp.kyoto-u.ac.jp075-751-3660

Outcome results